Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

2.63
+0.09503.75%
Post-market: 2.660.0300+1.14%19:30 EDT
Volume:3.46M
Turnover:9.06M
Market Cap:288.71M
PE:-15.47
High:2.78
Open:2.78
Low:2.52
Close:2.54
52wk High:5.45
52wk Low:2.42
Shares:109.77M
Float Shares:85.39M
Volume Ratio:1.70
T/O Rate:4.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:0.78
PE(LYR):-1.31

Loading ...

Rocket Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 11

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 11

Rocket Pharmaceuticals' Cardiac Programs Updates to Offer 'Strong' Share Price Catalysts, Wedbush Says

MT Newswires Live
·
May 09

Wedbush Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Artivion (AORT) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Rocket Pharmaceuticals Q1 EPS $(0.42) Beats $(0.43) Estimate

Benzinga Earnings
·
May 08

Rocket Pharma Q1 net loss narrows to $47.6 million; R&D expenses fall to $31.5 million

Reuters
·
May 08

Rocket Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
May 04

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)

TIPRANKS
·
Apr 29

Rocket Pharmaceuticals Inc : Leerink Partners Raises Target Price to $12 From $11

THOMSON REUTERS
·
Apr 28

Rocket Pharma sells priority review voucher for $180 million

Reuters
·
Apr 28

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

THOMSON REUTERS
·
Apr 28

Rocket Pharmaceuticals Inc - Cash Runway Extended Into Second Quarter of 2028

THOMSON REUTERS
·
Apr 28

LifeSci Capital Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Apr 20

Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar

TIPRANKS
·
Apr 17

US FDA's accelerated approval for drugs needs more transparency, says research firm

Reuters
·
Apr 16

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)

TIPRANKS
·
Apr 15